InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Voyager Therapeutics, Inc.

VYGR Clue Score26
United States Fiscal year ends December CIK 0001640266 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Todd Alfred Carter
15 Sep 2023
Chief Scientific Officer
Sold after exercise
10,500
$8.16
$85.68K
Todd Alfred Carter
30 Jun 2023
Chief Scientific Officer
Sold after exercise
5,000
$11.41
$57.05K
Jane Henderson
23 Mar 2018
Sr. V.P. & CFO, Corp. Dev.
Sold after exercise
11,200
$20.52
$229.82K
Jane Henderson
22 Mar 2018
Sr. V.P. & CFO, Corp. Dev.
Sold after exercise
19,900
$21.07
$419.29K
Jane Henderson
19 Mar 2018
CFO & SVP, Corp. Dev.
Sold after exercise
1,900
$21.76
$41.34K
Jane Henderson
16 Mar 2018
CFO & SVP, Corp. Dev.
Sold after exercise
15,416
$22.15
$341.46K
Dinah Ph.D. Sah
27 Feb 2018
Chief Scientific Officer
Sold after exercise
15,623
$30.00
$468.69K
Show all 123 transactions →

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 7
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 13,599,620
Sales filed before the plan box existed 67
History held since 18 Nov 2015